期刊文献+

CA125单克隆抗体的制备及其初步应用 被引量:3

Preparation of Monoclonal Antibody Against CA125 and It's Applications in Immunoassay
下载PDF
导出
摘要 利用CA125抗原免疫Balb/c小鼠,采用杂交瘤细胞技术,建立分泌抗CA125抗体的杂交瘤细胞株。将CA125单克隆抗体应用到化学发光免疫分析和免疫放射分析方法中,病理值的测定结果和进口试剂盒测定值相关方程分别为y=0.85x+11.1,r=0.932和y=0.87x-12.8,r=0.983;正常血样测量值范围分别为3.3~26.7和1.5~27.0U/mL。CA125单克隆抗体制备的包被板和包被管在37℃下可稳定存放14d,且不影响分析结果。 Balb/c mice were immunized with carbohydrate antigen 125 (CA125), and a competing sandwich immunoassay was used to screen positive clone of hybridoma cell, finally one monoclonal antibody against CA125 was got successfully. Applications of the antibody in immunoradiometric assay (IRMA) and chemiluminescence immunoassay (CLIA) show it is an ideal substitute of coating part in the sandwich system. We performed a normal range studies in which all healthy women had assay values less than 35 U/mL. A direct relationship exits between ELIA and IRMA with commercial kits, correlative equations are y=0.85x+11.1 (r=0. 932) in CLIA, y=0.87x-12.8(r= 0. 983) in IRMA, respectively. New antibody is stable at 37℃ for 2 weeks.
出处 《原子能科学技术》 EI CAS CSCD 北大核心 2008年第2期123-127,共5页 Atomic Energy Science and Technology
关键词 CA125 单克隆抗体 免疫放射分析 化学发光免疫分析 carbohydrate antigen 125 monoclonal antibody immunoradiometric assay chemiluminescence immunoassay
  • 相关文献

参考文献10

二级参考文献25

  • 1王玉肖,燕强奋,于洁.TSH双位点夹心免疫放射分析[J].同位素,1993,6(2):65-70. 被引量:4
  • 2韩立军,陈智周,范振符.CA-125免疫放射分析的动力学研究[J].标记免疫分析与临床,1995,2(3):158-160. 被引量:1
  • 3齐为民 王友臣 等.-[J].细胞与分子免疫学杂志,1999,15:40-42.
  • 4范振符 巴德年.肿瘤的免疫学检测.当代免疫学技术与应用[M].北京:北京医科大学中国协和医科大学联合出版社,1998.927-948.
  • 5Skates SJ, Xu FJ. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers[J].Cancer,1995,76(10 Suppl):2004-2010.
  • 6Davelaar EM, Schutter EM, Von S, et al. Clinical and technical evaluation of the ACS: OV serum assay and comparison with three other CA125-detecing assays[J].Ann Clin Biochem,2003,40:663.
  • 7Ardekani AM, Liotta LA, Petricoin EF, et al. Clinical potential of proteomics in the diagnosis of ovarian cancer[J].Expert Rev Mol Diagn,2002,2(4):312-320.
  • 8Hogdall EV, Hogdall CK, Tingulstad S, et al. Predictive values of serum tumor markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass[J].Int J Cancer,2000,89(6):519-523.
  • 9Jeyarajah AR, Ind TE, Macdonald N, et al. Increased mortality in postmenopausal women with serum CA125 elevation[J].Gynecol Oncol,1999,73(2):242-246.
  • 10Engelen MJ, de Bruijn HW, Hollema H, et al. Serum CA125, carcinoembryonic antigen, and CA19-9 as tumor markers in borderline tumors[J].Gynecol Oncol,2000,78(1):16-20.

共引文献43

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部